These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 26504072

  • 1. PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors.
    Lohneis P, Darb-Esfahani S, Dietel M, Braicu I, Sehouli J, Arsenic R.
    Anticancer Res; 2015 Nov; 35(11):6329-34. PubMed ID: 26504072
    [Abstract] [Full Text] [Related]

  • 2. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
    Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ.
    Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
    [Abstract] [Full Text] [Related]

  • 3. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
    Shen XX, Yu L, Bi R, Yang WT.
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637
    [Abstract] [Full Text] [Related]

  • 4. EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.
    Chen X, Wang X, Wei X, Wang J.
    J Ovarian Res; 2016 Nov 25; 9(1):83. PubMed ID: 27887627
    [Abstract] [Full Text] [Related]

  • 5. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA, Prinzler J, Sinn BV, Budczies J, Denkert C, Noske A, Sehouli J, Braicu EI, Dietel M, Darb-Esfahani S.
    Hum Pathol; 2013 Aug 25; 44(8):1465-71. PubMed ID: 23465277
    [Abstract] [Full Text] [Related]

  • 6. Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival.
    Gu Y, Li F, Qian N, Chen X, Wang H, Wang J.
    J Clin Pathol; 2016 May 25; 69(5):448-53. PubMed ID: 26468391
    [Abstract] [Full Text] [Related]

  • 7. Outcome in serous ovarian cancer is not associated with LATS expression.
    Montavon C, Stricker GR, Schoetzau A, Heinzelmann-Schwarz V, Jacob F, Fedier A.
    J Cancer Res Clin Oncol; 2019 Nov 25; 145(11):2737-2749. PubMed ID: 31586262
    [Abstract] [Full Text] [Related]

  • 8. Interferon-stimulated gene, 15 kDa (ISG15) in ovarian high-grade serous carcinoma: prognostic impact and link to NF-κB pathway.
    Darb-Esfahani S, Sinn BV, Rudl M, Sehouli J, Braicu I, Dietel M, Denkert C.
    Int J Gynecol Pathol; 2014 Jan 25; 33(1):16-22. PubMed ID: 24300530
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
    Unger U, Denkert C, Braicu I, Sehouli J, Dietel M, Loibl S, Darb-Esfahani S.
    Virchows Arch; 2017 Feb 25; 470(2):143-151. PubMed ID: 27913862
    [Abstract] [Full Text] [Related]

  • 11. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.
    Histol Histopathol; 2007 Nov 25; 22(11):1185-95. PubMed ID: 17647191
    [Abstract] [Full Text] [Related]

  • 12. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
    Mandelin E, Lassus H, Seppälä M, Leminen A, Gustafsson JA, Cheng G, Bützow R, Koistinen R.
    Cancer Res; 2003 Oct 01; 63(19):6258-64. PubMed ID: 14559812
    [Abstract] [Full Text] [Related]

  • 13. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q, Sun Y, Fei M, Zhang J, Jia Y, Gu M, Xia R, Chen S, Deng A.
    Neoplasma; 2012 Oct 01; 59(3):310-5. PubMed ID: 22296500
    [Abstract] [Full Text] [Related]

  • 14. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
    Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM.
    Clin Cancer Res; 2004 Oct 01; 10(19):6432-6. PubMed ID: 15475429
    [Abstract] [Full Text] [Related]

  • 15. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
    Darb-Esfahani S, Fritzsche F, Kristiansen G, Weichert W, Sehouli J, Braicu I, Dietel M, Denkert C.
    Virchows Arch; 2012 Aug 01; 461(2):109-16. PubMed ID: 22752467
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.
    Sehouli J, Braicu EI, Richter R, Denkert C, Jank P, Jurmeister PS, Kunze CA, Budczies J, Darb-Esfahani S, Schmitt WD, Traut A, Grabowski J, Taube ET, Plett H.
    Hum Pathol; 2019 Mar 01; 85():299-308. PubMed ID: 30428389
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.
    Wang H, Rosen DG, Wang H, Fuller GN, Zhang W, Liu J.
    Mod Pathol; 2006 Sep 01; 19(9):1149-56. PubMed ID: 16729015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
    Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B.
    Gynecol Oncol; 2013 May 01; 129(2):358-63. PubMed ID: 23438671
    [Abstract] [Full Text] [Related]

  • 20. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
    Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM.
    Int J Cancer; 2006 Aug 01; 119(3):599-607. PubMed ID: 16572426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.